Bayer Long-Term Investments 2010-2024 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.

Bayer Long-Term Investments 2010-2024 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$710.1B
Novo Nordisk (NVO)	$471.5B
Johnson & Johnson (JNJ)	$373.6B
AbbVie (ABBV)	$312.7B
Merck (MRK)	$250.9B
Novartis AG (NVS)	$213.1B
AstraZeneca (AZN)	$203.5B
Pfizer (PFE)	$145.4B
Sanofi (SNY)	$122.5B
Innoviva (INVA)	$1.2B